高遗传风险评分与系统性红斑狼疮早发、损伤累积及生存下降相关
该研究基于200K Immunochip对SLE患者(发现队列n=1001,复制队列n=5524)及健康对照进行基因分型,依据57个SLE风险位点计算遗传风险评分(GRS)。结果显示高GRS四分位组SLE患病风险显著升高,且与更早发病、更多器官损伤、肾脏受累、自身抗体阳性及生存下降相关。
要点
- 高GRS四分位组SLE患病风险显著高于低GRS组(发现队列OR 12.32)。
- 高GRS组患者平均发病早6年,损伤累积及肾脏受累风险更高。
- 高GRS组首次器官损伤、心血管事件、肾炎、ESRD及死亡风险均升高。
核心结论
- 高遗传风险评分与SLE患者器官损伤、肾功能不全及全因死亡风险增加相关。
- 遗传分析可能有助于预测SLE患者的结局。
研究设计与样本
- 研究采用200K Immunochip单核苷酸多态性芯片对SLE患者和健康对照进行基因分型。
- 发现队列纳入SLE患者1001例、健康对照2802例;复制队列纳入SLE患者5524例、健康对照9859例。
- 基于57个SLE风险位点为每个个体计算遗传风险评分(GRS)。
临床怎么用
- GRS可能作为SLE风险分层工具,辅助识别早发、器官损伤及不良预后高风险患者。
- 对高GRS患者可考虑更密切监测肾脏受累、自身抗体及心血管事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate associations between a high genetic disease risk and disease severity in patients with systemic lupus erythematosus (SLE). METHODS: Patients with SLE (n=1001, discovery cohort and n=5524, replication cohort) and healthy controls (n=2802 and n=9859) were genotyped using a 200K Immunochip single nucleotide polymorphism array. A genetic risk score (GRS) was assigned to each individual based on 57 SLE risk loci. RESULTS: SLE was more prevalent in the high, compared with the low, GRS-quartile (OR 12.32 (9.53 to 15.71), p=7.9×10-86 and OR 7.48 (6.73 to 8.32), p=2.2×10-304 for the discovery and the replication cohorts, respectively). In the discovery cohort, patients in the high GRS-quartile had a 6-year earlier mean disease onset (HR 1.47 (1.22 to 1.75), p=4.3×10-5), displayed higher prevalence of damage accrual (OR 1.47 (1.06 to 2.04), p=2.0×10-2), renal disorder (OR 2.22 (1.50 to 3.27), p=5.9×10-5), anti-dsDNA (OR 1.83 (1.19 to 2.81), p=6.1×10-3), end-stage renal disease (ESRD) (OR 5.58 (1.50 to 20.79), p=1.0×10-2), proliferative nephritis (OR 2.42 (1.30 to 4.49), p=5.1×10-3), anti-cardiolipin-IgG (OR 1.89 (1.13 to 3.18), p=1.6×10-2), anti-β2-glycoprotein-I-IgG (OR 2.29 (1.29 to 4.06), p=4.8×10-3) and positive lupus anticoagulant test (OR 2.12 (1.16 to 3.89), p=1.5×10-2) compared with patients in the low GRS-quartile. Survival analysis showed earlier onset of the first organ damage (HR 1.51 (1.04 to 2.25), p=3.7×10-2), first cardiovascular event (HR 1.65 (1.03 to 2.64), p=2.6×10-2), nephritis (HR 2.53 (1.72 to 3.71), p=9.6×10-7), ESRD (HR 6.78 (1.78 to 26.86), p=6.5×10-3) and decreased overall survival (HR 1.83 (1.02 to 3.30), p=4.3×10-2) in high to low quartile comparison. CONCLUSIONS: A high GRS is associated with increased risk of organ damage, renal dysfunction and all-cause mortality. Our results indicate that genetic profiling may be useful for predicting outcomes in patients with SLE.
引用
- Reid S, Alexsson A, Frodlund M, et al. High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus. Ann Rheum Dis. 2019. PMID: 31826855. doi:10.1136/annrheumdis-2019-216227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。